BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurevich VV, Gurevich EV. GPCRs and Signal Transducers: Interaction Stoichiometry. Trends Pharmacol Sci 2018;39:672-84. [PMID: 29739625 DOI: 10.1016/j.tips.2018.04.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Belyy V, Zuazo-Gaztelu I, Alamban A, Ashkenazi A, Walter P. Endoplasmic reticulum stress activates human IRE1α through reversible assembly of inactive dimers into small oligomers. Elife 2022;11:e74342. [PMID: 35730415 DOI: 10.7554/eLife.74342] [Reference Citation Analysis]
2 De Oliveira PA, Moreno E, Casajuana-Martin N, Casadó-Anguera V, Cai NS, Camacho-Hernandez GA, Zhu H, Bonifazi A, Hall MD, Weinshenker D, Newman AH, Logothetis DE, Casadó V, Plant LD, Pardo L, Ferré S. Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer. Pharmacol Res 2022;182:106322. [PMID: 35750299 DOI: 10.1016/j.phrs.2022.106322] [Reference Citation Analysis]
3 Adebayo OO, Dammer EB, Dill CD, Adebayo AO, Oseni SO, Griffen TL, Ohandjo AQ, Yan F, Jain S, Barwick BG, Singh R, Boise LH, Lillard, Jr. JW. Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers 2022;14:2228. [DOI: 10.3390/cancers14092228] [Reference Citation Analysis]
4 Karnam PC, Vishnivetskiy SA, Gurevich VV. Structural Basis of Arrestin Selectivity for Active Phosphorylated G Protein-Coupled Receptors. Int J Mol Sci 2021;22:12481. [PMID: 34830362 DOI: 10.3390/ijms222212481] [Reference Citation Analysis]
5 Poltavets V, Faulkner JW, Dhatrak D, Whitfield RJ, McColl SR, Kochetkova M. CXCR4-CCR7 Heterodimerization Is a Driver of Breast Cancer Progression. Life (Basel) 2021;11:1049. [PMID: 34685420 DOI: 10.3390/life11101049] [Reference Citation Analysis]
6 Ngamlertwong N, Tsuchiya H, Mochimaru Y, Azuma M, Kuchimaru T, Koshimizu TA. Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor. Sci Rep 2021;11:15813. [PMID: 34349143 DOI: 10.1038/s41598-021-94894-y] [Reference Citation Analysis]
7 Dominique M, Lucas N, Legrand R, Bouleté IM, Bôle-Feysot C, Deroissart C, Léon F, Nobis S, do Rego JC, Lambert G, Déchelotte P. Effects of Bacterial CLPB Protein Fragments on Food Intake and PYY Secretion. Nutrients 2021;13:2223. [PMID: 34209507 DOI: 10.3390/nu13072223] [Reference Citation Analysis]
8 Kang XL, Li YX, Li YL, Wang JX, Zhao XF. The homotetramerization of a GPCR transmits the 20-hydroxyecdysone signal and increases its entry into cells for insect metamorphosis. Development 2021;148:dev196667. [PMID: 33692089 DOI: 10.1242/dev.196667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gurevich EV, Gurevich VV. GRKs as Modulators of Neurotransmitter Receptors. Cells 2020;10:E52. [PMID: 33396400 DOI: 10.3390/cells10010052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Naider F, Becker JM. A Paradigm for Peptide Hormone-GPCR Analyses. Molecules 2020;25:E4272. [PMID: 32961885 DOI: 10.3390/molecules25184272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nishiguchi T, Yoshimura H, Kasai RS, Fujiwara TK, Ozawa T. Synergetic Roles of Formyl Peptide Receptor 1 Oligomerization in Ligand-Induced Signal Transduction. ACS Chem Biol 2020;15:2577-87. [PMID: 32808756 DOI: 10.1021/acschembio.0c00631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
12 Kleinau G, Heyder NA, Tao YX, Scheerer P. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor. Int J Mol Sci 2020;21:E5728. [PMID: 32785054 DOI: 10.3390/ijms21165728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Baidya M, Kumari P, Dwivedi-Agnihotri H, Pandey S, Chaturvedi M, Stepniewski TM, Kawakami K, Cao Y, Laporte SA, Selent J, Inoue A, Shukla AK. Key phosphorylation sites in GPCRs orchestrate the contribution of β-Arrestin 1 in ERK1/2 activation. EMBO Rep 2020;21:e49886. [PMID: 32715625 DOI: 10.15252/embr.201949886] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
14 Carotenuto AR, Lunghi L, Piccolo V, Babaei M, Dayal K, Pugno N, Zingales M, Deseri L, Fraldi M. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane. J Mech Phys Solids 2020;141:103974. [PMID: 32461703 DOI: 10.1016/j.jmps.2020.103974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Gurevich VV, Gurevich EV. Biased GPCR signaling: Possible mechanisms and inherent limitations. Pharmacol Ther 2020;211:107540. [PMID: 32201315 DOI: 10.1016/j.pharmthera.2020.107540] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
16 García-recio A, Navarro G, Franco R, Olivella M, Guixà-gonzález R, Cordomí A, Elofsson A. DIMERBOW: exploring possible GPCR dimer interfaces. Bioinformatics 2020;36:3271-2. [DOI: 10.1093/bioinformatics/btaa117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lutzu S, Castillo PE. Modulation of NMDA Receptors by G-protein-coupled receptors: Role in Synaptic Transmission, Plasticity and Beyond. Neuroscience 2021;456:27-42. [PMID: 32105741 DOI: 10.1016/j.neuroscience.2020.02.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Alansary D, Peckys DB, Niemeyer BA, de Jonge N. Detecting single ORAI1 proteins within the plasma membrane reveals higher-order channel complexes. J Cell Sci 2020;133:jcs240358. [PMID: 31822631 DOI: 10.1242/jcs.240358] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
19 Casadó-anguera V, Cortés A, Casadó V, Moreno E. Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs. Expert Opinion on Drug Discovery 2019;14:1297-312. [DOI: 10.1080/17460441.2019.1664469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Gurevich VV, Gurevich EV. Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies. Cell Mol Life Sci 2019;76:4413-21. [DOI: 10.1007/s00018-019-03272-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
21 Heyder N, Kleinau G, Szczepek M, Kwiatkowski D, Speck D, Soletto L, Cerdá-Reverter JM, Krude H, Kühnen P, Biebermann H, Scheerer P. Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective. Front Endocrinol (Lausanne) 2019;10:515. [PMID: 31417496 DOI: 10.3389/fendo.2019.00515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
22 Chavez-Abiega S, Goedhart J, Bruggeman FJ. Physical biology of GPCR signalling dynamics inferred from fluorescence spectroscopy and imaging. Curr Opin Struct Biol 2019;55:204-11. [PMID: 31319372 DOI: 10.1016/j.sbi.2019.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Gutzeit VA, Thibado J, Stor DS, Zhou Z, Blanchard SC, Andersen OS, Levitz J. Conformational dynamics between transmembrane domains and allosteric modulation of a metabotropic glutamate receptor. Elife 2019;8:e45116. [PMID: 31172948 DOI: 10.7554/eLife.45116] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
24 Quast RB, Margeat E. Studying GPCR conformational dynamics by single molecule fluorescence. Mol Cell Endocrinol 2019;493:110469. [PMID: 31163201 DOI: 10.1016/j.mce.2019.110469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
25 Insel PA, Sriram K, Gorr MW, Wiley SZ, Michkov A, Salmerón C, Chinn AM. GPCRomics: An Approach to Discover GPCR Drug Targets. Trends Pharmacol Sci 2019;40:378-87. [PMID: 31078319 DOI: 10.1016/j.tips.2019.04.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
26 Kenakin T, Barker EL. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267-315. [DOI: 10.1124/pr.118.016790] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 30.3] [Reference Citation Analysis]
27 Corradi V, Sejdiu BI, Mesa-Galloso H, Abdizadeh H, Noskov SY, Marrink SJ, Tieleman DP. Emerging Diversity in Lipid-Protein Interactions. Chem Rev 2019;119:5775-848. [PMID: 30758191 DOI: 10.1021/acs.chemrev.8b00451] [Cited by in Crossref: 142] [Cited by in F6Publishing: 109] [Article Influence: 47.3] [Reference Citation Analysis]
28 Sleno R, Hébert TE. Shaky ground - The nature of metastable GPCR signalling complexes. Neuropharmacology 2019;152:4-14. [PMID: 30659839 DOI: 10.1016/j.neuropharm.2019.01.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
29 Milligan G, Ward RJ, Marsango S. GPCR homo-oligomerization. Curr Opin Cell Biol 2019;57:40-7. [PMID: 30453145 DOI: 10.1016/j.ceb.2018.10.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
30 Shimada I, Ueda T, Kofuku Y, Eddy MT, Wüthrich K. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat Rev Drug Discov 2019;18:59-82. [PMID: 30410121 DOI: 10.1038/nrd.2018.180] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 24.3] [Reference Citation Analysis]
31 Wanka L, Babilon S, Kaiser A, Mörl K, Beck-sickinger AG. Different mode of arrestin-3 binding at the human Y 1 and Y 2 receptor. Cellular Signalling 2018;50:58-71. [DOI: 10.1016/j.cellsig.2018.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
32 Borlepawar A, Frey N, Frank D. Editorial commentary: Epithelial-to-Mesenchymal transition and G protein-coupled receptors: A novel possibility for cardiac regeneration? Trends Cardiovasc Med 2019;29:205-6. [PMID: 30268649 DOI: 10.1016/j.tcm.2018.09.008] [Reference Citation Analysis]
33 Burger WAC, Sexton PM, Christopoulos A, Thal DM. Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors. J Gen Physiol 2018;150:1360-72. [PMID: 30190312 DOI: 10.1085/jgp.201711979] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
34 Wold EA, Chen J, Cunningham KA, Zhou J. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. J Med Chem 2019;62:88-127. [PMID: 30106578 DOI: 10.1021/acs.jmedchem.8b00875] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
35 Nebigil CG, Désaubry L. The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT). Trends Cardiovasc Med 2019;29:200-4. [PMID: 30172578 DOI: 10.1016/j.tcm.2018.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]